Machine Learning

Forbes' 40th list reveals 3,428 billionaires worth a record $20.1T, as an AI market surge pushes Elon Musk's fortune to an unprecedented $839 billion.

The telehealth giant is launching a new vertical for healthy aging, aiming to fix a market that has historically ignored women's specific biological needs.

Following a major investment, Trialbee appoints a seasoned leader to its board, signaling a push for dominance in AI-driven clinical trial recruitment.

A new analysis shows AI platforms can cut hospital costs by $2M annually while reducing ICU stays and ventilation time, transforming critical care.

At CERAWeek 2026, energy infrastructure leader Williams will outline its strategy for leveraging natural gas to power the AI and data center boom.

Samsara's new AI coaching features promise to reduce crashes and empower managers, but raise questions about driver privacy in an increasingly automated industry.

Rainforest Distribution is betting on a unified, AI-powered platform from Manhattan Associates to navigate the volatile food and beverage landscape.

NeuroThera Labs' $9.46M acquisition of CliniQuantum signals a bold move to revolutionize drug development with next-generation quantum computing.

Atera's new AI agent, Robin, aims to autonomously resolve tech issues, backed by a 'Let People Work' campaign. Can it truly end the IT helpdesk ticket?

Employer confidence is back to 2022 levels, but a new survey reveals AI's uneven impact and hiring plans were made before new geopolitical tensions.

A new study reveals communications pros are gaining unprecedented C-suite power but feel unprepared for an AI-driven future, risking a major talent exodus.

A new strategic partnership aims to solve the data fragmentation crisis in mining and energy, paving the way for true AI-driven efficiency and safety.

Confluent Cloud for Government has achieved FedRAMP Moderate authorization, enabling federal agencies to adopt real-time data streaming to modernize services.

Newtek Bank launches a seven-day business loan up to $350k, using AI to offer a 10-year term that directly challenges high-cost, short-term financing.

New analysis of Phase 1 data for NKGen Biotech’s troculeucel suggests cognitive benefits, offering a potential new weapon against neuroinflammation.

After its Alzheimer's drug failed amidst controversy, Cassava Sciences rebrands as Filana Therapeutics, betting its future on a rare epilepsy disorder.

With its new Disaggregated Spine architecture and ultra-efficient switches, Nexthop AI aims to slash costs and power use for hyperscalers and NeoClouds.

In the quest to drug the 'undruggable,' Erasca consolidates worldwide control of its promising pan-RAS inhibitor, setting the stage for a global showdown.

A new AI biomarker analyzes blood vessels in CT scans, offering earlier, more accurate predictions of which patients will benefit from immunotherapy.

With a new Wabash partnership, SpecSync aims to slash complex equipment quote times from weeks to minutes, signaling a major shift for industrial sales.